Stockreport

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... [Yahoo! Finance]

Novavax, Inc.  (NVAX) 
Last novavax, inc. earnings: 3/11 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novavax.com/investor-relations
PDF Cost of Sales: $61 million for Q3 2024, compared to $99 million in Q3 2023. R&D and SG&A Expenses: $158 million for Q3 2024, a 26% reduction from Q3 2023. Cash Posi [Read more]